How many pediatric exclusivity determinations has the FDA made in 2026?

As of July 16, 2026, the U.S. Food and Drug Administration reported a total of 354 pediatric exclusivity determinations under Section 505A of the Federal Food, Drug, and Cosmetic Act. These cover 321 approved active moieties and 336 approved drugs, reflecting ongoing FDA activity in pediatric exclusivity extensions.